BeiGene Shares Rise on First Dosing of Brukinsa : vimarsana.com

By Dean Seal


American depositary receipts of BeiGene jumped after the company said the first doses of its lymphocytic leukemia treatment Brukinsa have been administered to patients in Armenia...

Related Keywords

Nepal , Armenia , United States , American , , Max Foundation , Dean Seal , Dow Jones , Markets ,